Bank of The Ozarks lowered its position in Mylan N.V. (NASDAQ:MYL) by 0.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,182 shares of the company’s stock after selling 38 shares during the period. Bank of The Ozarks’ holdings in Mylan N.V. were worth $240,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State of Alaska Department of Revenue purchased a new stake in shares of Mylan N.V. during the first quarter worth $188,000. Rothschild Investment Corp IL increased its stake in shares of Mylan N.V. by 28.3% in the first quarter. Rothschild Investment Corp IL now owns 11,240 shares of the company’s stock worth $438,000 after buying an additional 2,480 shares during the period. Columbus Circle Investors purchased a new stake in shares of Mylan N.V. during the first quarter worth $2,266,000. Nisa Investment Advisors LLC increased its stake in shares of Mylan N.V. by 0.7% in the first quarter. Nisa Investment Advisors LLC now owns 82,107 shares of the company’s stock worth $3,201,000 after buying an additional 550 shares during the period. Finally, Bank of The West increased its stake in shares of Mylan N.V. by 4.9% in the first quarter. Bank of The West now owns 72,582 shares of the company’s stock worth $2,830,000 after buying an additional 3,360 shares during the period. Hedge funds and other institutional investors own 70.19% of the company’s stock.

Mylan N.V. (NASDAQ:MYL) opened at 32.08 on Thursday. The stock’s 50 day moving average is $37.74 and its 200 day moving average is $39.09. Mylan N.V. has a 1-year low of $29.58 and a 1-year high of $49.42. The company has a market cap of $17.19 billion, a P/E ratio of 32.05 and a beta of 1.27. Mylan N.V. also saw some unusual options trading activity on Monday. Investors bought 9,410 call options on the stock. This is an increase of 250% compared to the average volume of 2,688 call options.

Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a net margin of 4.59% and a return on equity of 23.69%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the company posted $1.16 earnings per share. The business’s revenue for the quarter was up 15.7% compared to the same quarter last year. Equities analysts anticipate that Mylan N.V. will post $4.86 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Bank of The Ozarks Has $240,000 Stake in Mylan N.V. (MYL)” was published by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/10/bank-of-the-ozarks-has-240000-stake-in-mylan-n-v-myl.html.

A number of brokerages have recently weighed in on MYL. Royal Bank Of Canada set a $41.00 price target on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Saturday, May 13th. Wells Fargo & Company set a $30.00 price target on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday. Cantor Fitzgerald set a $34.00 price target on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday. Cowen and Company set a $30.00 price target on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday. Finally, Morgan Stanley cut their price target on shares of Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating for the company in a report on Monday. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $48.78.

In related news, insider Anthony Mauro sold 10,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the sale, the insider now directly owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Rajiv Malik sold 25,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the sale, the president now directly owns 799,855 shares in the company, valued at $31,994,200. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.